Irreversible Inactivation of Protein Kinase C by Glutathione*

The tripeptide glutathione (GSH) is the predominant low molecular weight thiol reductant in mammalian cells. In this report, we show that at concentrations at which GSH is typically present in the intracellular milieu, GSH and the oxidized GSH derivatives GSH disulfide (GSSG) and glutathione sulfonate each irreversibly inactivate up to 100% of the activity of purified Ca2+- and phosphatidylserine (PS)-dependent protein kinase C (PKC) isozymes in a concentration-dependent manner by a novel nonredox mechanism that requires neither glutathiolation of PKC nor the reduction, formation, or isomerization of disulfide bridges within PKC. Our evidence for a nonredox mechanism of PKC inactivation can be summarized as follows. GSSG antagonized the Ca2+- and PS-dependent activity of purified rat brain PKC with the same efficacy (IC50 = 3 mm) whether or not the reductant dithiothreitol was present. Glutathione sulfonate, which is distinguished from GSSG and GSH by its inability to undergo disulfide/thiol exchange reactions, was as effective as GSSG in antagonizing Ca2+- and PS-dependent PKC catalysis. The irreversibility of the inactivation mechanism was indicated by the stability of the inactivated form of PKC to dilution and extensive dialysis. The inactivation mechanism did not involve the nonspecific phenomena of denaturation and aggregation of PKC because it obeyed pseudo-first order kinetics and because the hinge region of PKC-α remained a preferential target of tryptic attack following GSH inactivation. The selectivity of GSH in the inactivation of PKC was also indicated by the lack of effect of the tripeptides Tyr-Gly-Gly and Gly-Ala-Gly on the activity of PKC. Furthermore, GSH antagonism of the Ser/Thr kinase casein kinase 2 was by comparison weak (<25%). Inactivation of PKC-α was not accompanied by covalent modification of the isozyme by GSH or other irreversible binding interactions between PKC-α and the tripeptide, but it was associated with an increase in the susceptibility of PKC-α to trypsinolysis. Treatment of cultured rat fibroblast and human breast cancer cell lines withN-acetylcysteine resulted in a substantial loss of Ca2+- and PS- dependent PKC activity in the cells within 30 min. These results suggest that GSH exerts negative regulation over cellular PKC isozymes that may be lost when oxidative stress depletes the cellular GSH pool.

[1]  R. Epand,et al.  Substrate-Induced Translocation of PKC-α to the Membrane , 1995 .

[2]  B. Levin,et al.  Evidence that protein kinase C-alpha activation is a critical event in phorbol ester-induced multiple drug resistance in human colon cancer cells. , 1994, Biochemical pharmacology.

[3]  P. Mehlen,et al.  hsp27 as a Switch between Differentiation and Apoptosis in Murine Embryonic Stem Cells* , 1997, The Journal of Biological Chemistry.

[4]  J. A. Thomas,et al.  Protein sulfhydryls and their role in the antioxidant function of protein S-thiolation. , 1995, Archives of biochemistry and biophysics.

[5]  G. Martiny-Baron,et al.  Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976. , 1993, The Journal of biological chemistry.

[6]  C. Schmitz‐Peiffer,et al.  Molecular cloning and characterization of PKC iota, an atypical isoform of protein kinase C derived from insulin-secreting cells. , 1993, The Journal of biological chemistry.

[7]  B. Kemp,et al.  Protein kinase CK2: biphasic kinetics with peptide substrates. , 1996, Archives of biochemistry and biophysics.

[8]  P. Bergman,et al.  Partial Reversal of Multidrug Resistance in Human Breast Cancer Cells by an N-Myristoylated Protein Kinase C- Pseudosubstrate Peptide (*) , 1996, The Journal of Biological Chemistry.

[9]  N. Ward,et al.  Covalent Modification of Protein Kinase C Isozymes by the Inactivating Peptide Substrate Analog N-Biotinyl-Arg-Arg-Arg-Cys-Leu-Arg-Arg-Leu , 1996, The Journal of Biological Chemistry.

[10]  F. Quiocho,et al.  Specifically Targeted Modification of Human Aldose Reductase by Physiological Disulfides* , 1996, The Journal of Biological Chemistry.

[11]  P. Parker,et al.  Identification of the phosphorylated region responsible for the permissive activation of protein kinase C. , 1993, The Journal of biological chemistry.

[12]  P. Parker,et al.  Phosphorylation of threonine 638 critically controls the dephosphorylation and inactivation of protein kinase Cα , 1996, Current Biology.

[13]  A. Ullrich,et al.  Protein kinase C , 1987, Journal of cellular physiology. Supplement.

[14]  W. R. Bishop,et al.  Phosphorylation of Thr642 is an early event in the processing of newly synthesized protein kinase C beta 1 and is essential for its activation. , 1994, The Journal of biological chemistry.

[15]  R. Epand,et al.  Protein kinase C : current concepts and future perspectives , 1992 .

[16]  S. Taylor,et al.  Affinity labeling of the nucleotide binding site of the catalytic subunit of cAMP-dependent protein kinase using p-fluorosulfonyl-[14C]benzoyl 5'-adenosine. Identification of a modified lysine residue. , 1979, The Journal of biological chemistry.

[17]  Y Nishizuka,et al.  Synergistic action of diacylglycerol and unsaturated fatty acid for protein kinase C activation: its possible implications. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[18]  N. Ward,et al.  Inhibition of protein kinase C by melittin: antagonism of binding interactions between melittin and the catalytic domain by active-site binding of MgATP. , 1994, Biochemical pharmacology.

[19]  B. Kemp,et al.  Protein kinase C contains a pseudosubstrate prototope in its regulatory domain. , 1987, Science.

[20]  H. Hug,et al.  Sequence of human protein kinase C α , 1990 .

[21]  L. Greene,et al.  N-Acetylcysteine-promoted Survival of PC12 Cells Is Glutathione-independent but Transcription-dependent (*) , 1995, The Journal of Biological Chemistry.

[22]  D. Burns,et al.  Expression of the alpha, beta II, and gamma protein kinase C isozymes in the baculovirus-insect cell expression system. Purification and characterization of the individual isoforms. , 1990, The Journal of biological chemistry.

[23]  N. Ward,et al.  Inhibition of protein kinase C by N-myristoylated peptide substrate analogs. , 1993, Biochemistry.

[24]  Y. Hannun,et al.  Ceramide Inactivates Cellular Protein Kinase Cα* , 1996, The Journal of Biological Chemistry.

[25]  A. Newton,et al.  Regulation of protein kinase C. , 1997, Current opinion in cell biology.

[26]  P. Wingfield,et al.  Regulation of HIV-1 protease activity through cysteine modification. , 1996, Biochemistry.

[27]  A. Newton,et al.  Requirement for negative charge on "activation loop" of protein kinase C. , 1994, The Journal of biological chemistry.

[28]  J. Hurley,et al.  Crystal structure of the Cys2 activator-binding domain of protein kinase Cδ in complex with phorbol ester , 1995, Cell.

[29]  Y. Hannun,et al.  The sphingomyelin cycle and the second messenger function of ceramide. , 1994, The Journal of biological chemistry.

[30]  R. Levine,et al.  The phosphatase activity of carbonic anhydrase III is reversibly regulated by glutathiolation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Mark D. Johnson,et al.  Overproduction of protein kinase C causesdisordered growth control in rat fibroblasts , 1988, Cell.

[32]  N. Ward,et al.  Characterization of a Ca2(+)- and phospholipid-dependent ATPase reaction catalyzed by rat brain protein kinase C. , 1990, Biochemistry.

[33]  Y. Hannun,et al.  Inhibition of the Neutral Magnesium-dependent Sphingomyelinase by Glutathione* , 1997, The Journal of Biological Chemistry.

[34]  A. Colell,et al.  Tumor Necrosis Factor Increases Hepatocellular Glutathione by Transcriptional Regulation of the Heavy Subunit Chain of γ-Glutamylcysteine Synthetase* , 1997, The Journal of Biological Chemistry.

[35]  Y. Nishizuka Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. , 1992, Science.

[36]  N. Ward,et al.  Irreversible Inactivation of Protein Kinase C by a Peptide-Substrate Analog (*) , 1995, The Journal of Biological Chemistry.

[37]  A. Newton,et al.  Ca2+ Differentially Regulates Conventional Protein Kinase Cs’ Membrane Interaction and Activation* , 1997, The Journal of Biological Chemistry.

[38]  R. Foresti,et al.  Thiol Compounds Interact with Nitric Oxide in Regulating Heme Oxygenase-1 Induction in Endothelial Cells , 1997, The Journal of Biological Chemistry.

[39]  L. Atzori,et al.  Modifications of cellular thiols during growth and squamous differentiation of cultured human bronchial epithelial cells. , 1994, Experimental cell research.

[40]  K. Rokutan,et al.  S-thiolation of individual human neutrophil proteins including actin by stimulation of the respiratory burst: evidence against a role for glutathione disulfide. , 1994, Archives of biochemistry and biophysics.

[41]  P. Parker,et al.  12-O-Tetradecanoylphorbol-13-acetate-induced Dephosphorylation of Protein Kinase Cα Correlates with the Presence of a Membrane-associated Protein Phosphatase 2A Heterotrimer* , 1996, The Journal of Biological Chemistry.

[42]  D. Fabbro,et al.  Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrug-resistant MCF-7 cells. Functional significance of enhanced expression of PKC alpha. , 1993, The Journal of biological chemistry.

[43]  W. Anderson,et al.  Retinoids inhibit the oxidative modification of protein kinase C induced by oxidant tumor promoters. , 1993, Archives of biochemistry and biophysics.

[44]  N. Zandwijk N‐Acetylcysteine (NAC) and glutathione (GSH): Antioxidant and chemopreventive properties, with special reference to lung cancer , 1995 .

[45]  Y. Nishizuka,et al.  The common structure and activities of four subspecies of rat brain protein kinase C family , 1987, FEBS letters.

[46]  Y. Hannun,et al.  Protein kinase C isoenzymes: regulation and function. , 1996, Cancer surveys.